These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Hyperparathyroidism secondary to cirrhosis. Arguments supplied by ionized calcium, urinary cyclic AMP and blood N-terminal parathyroid hormone]. Louboutin JY; Feuillu A; Allain H; Bernat M; Meadeb J; Pawlotsky Y Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):707-13. PubMed ID: 6256846 [TBL] [Abstract][Full Text] [Related]
3. [Value and relevance of metabolic function tests in the diagnosis of primary hyperparathyroidism (author's transl)]. Schweigart U; Henderkott U; Paterek K; Hartung R; Zilker T; Bottermann P Med Klin; 1976 Feb; 71(7):281-5. PubMed ID: 176561 [TBL] [Abstract][Full Text] [Related]
4. Ionized calcium and cyclic AMP in plasma and urine. Biochemical evaluation in calcium metabolic disease. Thode J Scand J Clin Lab Invest Suppl; 1990; 197():1-45. PubMed ID: 2154030 [TBL] [Abstract][Full Text] [Related]
5. Grouping of patients with hyperparathyroidism by clinical signs, correlated to some biochemical findings. Andersson R; Gillquist J; Larsson L; Kågedal B Acta Chir Scand; 1976; 142(8):567-73. PubMed ID: 202128 [TBL] [Abstract][Full Text] [Related]
6. Urinary parameters as predictors of primary hyperparathyroidism in patients with nephrolithiasis. Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML J Urol; 2012 Feb; 187(2):516-21. PubMed ID: 22177167 [TBL] [Abstract][Full Text] [Related]
7. Renal calcium conservation in recurrent stone-formers with idiopathic hypercalciuria. Goulding A; Hocken AG N Z Med J; 1985 Feb; 98(772):50-2. PubMed ID: 2983270 [TBL] [Abstract][Full Text] [Related]
8. [PTH, cyclic AMP and hydroxyproline. Diagnostic importance in hypercalciuria and primary hyperparathyroidism]. Barceló P; Novillo R; Covarsí A; Brassesco M; Del Rio G Acta Med Port; 1983; 4(9-10):399-402. PubMed ID: 6318522 [No Abstract] [Full Text] [Related]
9. [Usefulness of the determination of nephrogenous cyclic AMP in the diagnosis of primary hyperparathyroidism]. Bill G; Jacquet AF; Burckhardt P Schweiz Med Wochenschr; 1983 Mar; 113(9):327-30. PubMed ID: 6302835 [TBL] [Abstract][Full Text] [Related]
10. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies. Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460 [TBL] [Abstract][Full Text] [Related]
11. Urinary cyclic AMP as an aid in the differential diagnosis of hypercalcemia. Debacker M; Manderlier T; Nijs-Dewolf N; Six R; Corvilain J Biomedicine; 1974 Aug; 21(8):338-41. PubMed ID: 4374265 [No Abstract] [Full Text] [Related]
12. Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism. Elaraj DM; Remaley AT; Simonds WF; Skarulis MC; Libutti SK; Bartlett DL; Venzon DJ; Marx SJ; Alexander HR Surgery; 2002 Dec; 132(6):1028-33; discussion 1033-4. PubMed ID: 12490851 [TBL] [Abstract][Full Text] [Related]
18. Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism. Heath H; Purnell DC J Lab Clin Med; 1980 Dec; 96(6):974-84. PubMed ID: 6253580 [TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of cyclic AMP in hyperparathyroidism. Wålinder O; Ljunghall S; Wibell L Scand J Urol Nephrol; 1978; 12(1):67-71. PubMed ID: 204993 [TBL] [Abstract][Full Text] [Related]
20. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]